Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common stock, par value $0.00001
-
Shares outstanding
-
43,754,363
-
Total 13F shares
-
1,881,137
-
Share change
-
+1,266,407
-
Total reported value
-
$3,216,474
-
Price per share
-
$1.71
-
Number of holders
-
23
-
Value change
-
+$2,148,424
-
Number of buys
-
14
-
Number of sells
-
2
Institutional Holders of Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB) as of Q4 2022
As of 31 Dec 2022,
Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,881,137 shares.
The largest 10 holders included
AIGH Capital Management LLC, Worth Venture Partners, LLC, VANGUARD GROUP INC, CVI Holdings, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Maven Securities LTD, CITADEL ADVISORS LLC, and STATE STREET CORP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.